| APO |
Report |
Adjusted Net Income / EPS |
BEAT |
pred ~$2.18 vs. cons $2.15 |
MEDIUM |
| APO |
Report |
Total inflows (organic) |
BEAT |
pred ~$53B vs. cons $50.4B |
MEDIUM |
| APO |
Report |
Athene net spread / SRE (bps) |
IN-LINE |
pred ~119 bps vs. cons ~121 bps (SRE ~$1.16/sh vs cons ~$1.17) |
MEDIUM |
| APO |
Guide |
FY2026 FRE growth |
UNCHANGED |
guide reaffirmed ~20%+ vs. cons ~20% (FY2026) |
HIGH |
| APO |
Guide |
FY2026 SRE growth |
UNCHANGED |
guide reaffirmed ~10% vs. cons ~10% (FY2026, 11% alts assumption) |
MEDIUM |
| APO |
Guide |
FY2026 net spread range |
UNCHANGED |
guide ~120-125 bps vs. cons ~122 bps (FY2026) |
MEDIUM |
| APO |
Guide |
Q2 origination commentary |
BETTER |
guide ~$85-90B, near record vs. cons ~$80B (2026Q2) |
MEDIUM |
| APO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
LOW |
| APO |
Return |
5-day cumulative residual |
-1.5% (FADE) |
Stock ran up ~5.5% residual into the print (APO +7.7% vs SPY +2.2% over two sessions), so an operationally strong FRE/origination beat is largely priced. With SRE/net spread only stabilizing (not beating) and persistent private-credit/BDC overhang, out-period math and modest downward SRE revisions plus 'sell-the-news' positioning pull the initial pop back over the following week. |
LOW |